Adimab Newswire

Adimab Newswire

Comprehensive Real-Time News Feed for Adimab.

Results 1 - 6 of 6 in Adimab

  1. Adimab Announces Antibody Discovery Collaboration with Boehringer IngelheimRead the original story

    Wednesday Jan 10 | Customer Interaction Solutions

    Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Boehringer Ingelheim . Under the terms of the agreement, Adimab will use its proprietary platform to discover and optimize antibodies against targets chosen by BI, who will have the rights to develop and commercialize therapeutic programs resulting from the collaboration.

    Comment?

  2. Global Antibody Library Technologies Market: Phage Display Segment by ...Read the original story w/Photo

    Sep 1, 2017 | SBWire

    ... entered into a collaboration agreement with Janssen Biotech Inc. - a Johnson & Johnson Company - In April 2016, Adimab LLC announced the signing of a collaboration agreement with Takeda Pharmaceutical Company Ltd. - In January 2016, Adimab LLC ...

    Comment?

  3. Global Biologics Outsourcing Market Is Expected to Grow at Double...Read the original story w/Photo

    Aug 22, 2017 | SBWire

    ... Global Market - Cell Line Development, Company Profiles. This Report Covered 33 Companies Few Are - Abzena Plc, Adimab Llc, Albany Molecular Research, Inc, Beijing Vital Star Biotechnology Co. Ltd., Boehringer Ingelheim, Catalent Inc., Charles River ...

    Comment?

  4. Adimab Announces Platform Transfer with LillyRead the original story

    Jul 18, 2017 | Customer Interaction Solutions

    Adimab, LLC, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it has entered into an agreement with Eli Lilly and Company to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas. This technology transfer expands an ongoing collaboration between the two companies that was initiated in 2010, which has yielded several undisclosed therapeutic candidates for Lilly.

    Comment?

  5. Global Market Study on Antibody Library Technologies Phage Display SegmentRead the original story w/Photo

    Jun 26, 2017 | SBWire

    ... entered into a collaboration agreement with Janssen Biotech Inc. - a Johnson & Johnson Company In April 2016, Adimab LLC announced the signing of a collaboration agreement with Takeda Pharmaceutical Company Ltd. In January 2016, Adimab LLC licensed ...

    Comment?

  6. Adimab LLC. Provides Mid-Year Update On 2017 Partnership ActivityRead the original story

    Jun 20, 2017 | BioSpace

    Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in the first half of 2017 it entered into agreements with six new companies. In addition, Adimab announced the expansion of four of its current partnerships and the achievement of over 20 technical and development milestones across multiple existing collaborations.

    Comment?